FDA Proposes Process Modernization to Support New Drug Development

By: Janet Woodcock, M.D. The staff of the FDA’s Center for Drug Evaluation and Research (CDER) always tries to utilize cutting-edge science and up-to-date process management, befitting our stature as the global “gold standard” in drug regulation. Maintaining that standard … Continue reading →
Source: FDA Voice - Category: American Health Source Type: blogs